Effective prioritization plays critical roles in precision medicine. Healthcare decisions are complex, involving trade-offs among numerous frequently contradictory priorities. Considering the numerous difficulties associated with COVID-19, approaches that could triage COVID-19 patients may help in prioritizing treatment and provide precise medicine for those who are at risk of serious disease. Prioritizing a patient with COVID-19 depends on a variety of examination criteria, but due to the large number of these biomarkers, it may be hard for medical practitioners and emergency systems to decide which cases should be given priority for treatment. The aim of this paper is to propose a Multidimensional Examination Framework (MEF) for the prioritization of COVID-19 severe patients on the basis of combined multi-criteria decision-making (MCDM) methods. In contrast to the existing literature, the MEF has not considered only a single dimension of the examination factors; instead, the proposed framework included different multidimensional examination criteria such as demographic, laboratory findings, vital signs, symptoms, and chronic conditions. A real dataset that consists of data from 78 patients with different examination criteria was used as a base in the construction of Multidimensional Evaluation Matrix (MEM). The proposed framework employs the CRITIC (CRiteria Importance Through Intercriteria Correlation) method to identify objective weights and importance for multidimensional examination criteria. Furthermore, the VIKOR (VIekriterijumsko KOmpromisno Rangiranje) method is utilized to prioritize COVID-19 severe patients. The results based on the CRITIC method showed that the most important examination criterion for prioritization is COVID-19 patients with heart disease, followed by cough and nasal congestion symptoms. Moreover, the VIKOR method showed that Patients 8, 3, 9, 59, and 1 are the most urgent cases that required the highest priority among the other 78 patients. Finally, the proposed framework can be used by medical organizations to prioritize the most critical COVID-19 patient that has multidimensional examination criteria and to promptly give appropriate care for more precise medicine.
28 November 2022 in Computational Intelligence and Neuroscience
Cell phenotype classification is a critical task in many medical applications, such as protein localization, gene effect identification, and cancer diagnosis in some types. Fluorescence imaging is the most efficient tool to analyze the biological characteristics of cells. So cell phenotype classification in fluorescence microscopy images has received increased attention from scientists in the last decade. The visible structures of cells are usually different in terms of shape, texture, relationship between intensities, etc. In this scope, most of the presented approaches use one type or joint of low-level and high-level features. In this paper, a new approach is proposed based on a combination of low-level and high-level features. An improved version of local quinary patterns is used to extract low-level texture features. Also, an innovative multilayer deep feature extraction method is performed to extract high-level features from DenseNet. In this respect, an output feature map of dense blocks is entered in a separate way to pooling and flatten layers, and finally, feature vectors are concatenated. The performance of the proposed approach is evaluated on the benchmark dataset 2D-HeLa in terms of accuracy. Also, the proposed approach is compared with state-of-the-art methods in terms of classification accuracy. Comparison of results demonstrates higher performance of the proposed approach in comparison with some efficient methods.
1 November 2021 in IOP Conference Series: Earth and Environmental Science
A modest quantity of fluoride can increase the mineralization of teeth and reduce their cavities. But the presomerence of fluoride in excess in water can lead to severe disease infertility. In the past few decades, scientists have thus been preoccupied with developing ways to reduce sewage fluoride concentrations and reduce their effects on human health. The present study is aimed at using the technology of electrocoagulation to remove fluoride from polluted water. Tests have been done to examine the elimination of fluoride with a rectangular electrocoagulation cell and examine the impact of the experimental aspects on fluoride extraction, specifically electrical current, electrode spacing, and pH. The authors found that 93% of the fluoride has been extracted using 5mm spaced electrodes with a current density of 2 mA/cm2 and a level of pH of 7 from the polluted water after 20 min of processing. Experimental factors considerably impact the efficacy of fluoride removal. In the acidic environment, greater effectiveness of fluoride removal is being attained. The elimination effectiveness depends directly on the electric current, whereas the distance between poles is adversely linked to fluoride elimination.
1 January 2022 in Journal of Advanced Biotechnology and Experimental Therapeutics
Background Type 1 diabetes mellitus (T1DM), also known as autoimmune diabetes, is a chronic disease characterized by insulin deficiency due to pancreatic β-cell loss and leads to hyperglycaemia. The T cell-mediated destruction of β-cells is-targeting insulin, glutamic acid decarboxylase (GAD), insulinoma-associated protein 2 and zinc transporter. The GAD biomarker of T1DM is found months to years before symptoms onset and can be used to identify and study individuals who are at risk for developing T1DM. Objective To evaluate the role of GAD in diagnosis of T1DM and to compare the new diagnostic marker, anti-GAD, associations with future disease activity and compared to type 2 DM. Material and Method This study involved fifty six (56) blood and serum samples from patients suffering from T1DM, (12) patients with type 2DM and (12) healthy individuals as controls. The average disease duration was 6.5±0.5 years (1-15years). Anti-GAD antibody assayed as biomarker parameter for all subjects. Anti-GAD as it was tested by Chorus device (ELISA automated device) as semi quantitative determination. All clinical features were investigated by questionnaire interviews. Data were presented as frequencies and percentages. Results Male patients with T1DM appeared to be more affected than women. The results also showed elevated levels of anti-GAD in 51.8% of T1DM. In a random sample of (12) non-diabetic individuals, none had anti-GAD. The sensitivity of the anti-GAD test for T1DM was 82.2% and the specificity was 93%. Conclusion Prevalence of Anti-GAD is associated with age. Patients with Type 1DM (Children and adolescents) had increased prevalence of Anti-GAD antibodies. The positivity of anti-GAD antibodies was higher in children and adolescents and less frequent in adult patients involved in this study. So it could be a useful serological assay in establishing the diagnosis of type 1DM and prediction of very high risk for development of T1DM.